Financials Grifols, S.A.

Equities

GRF

ES0171996087

Pharmaceuticals

Market Closed - BME 11:35:22 2024-05-03 am EDT After market 11:51:35 am
8.89 EUR +1.69% Intraday chart for Grifols, S.A. 8.859 -0.35%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 18,760 14,161 9,783 6,557 9,231 5,219 - -
Enterprise Value (EV) 1 25,225 20,597 16,478 15,716 18,568 14,317 13,801 13,401
P/E ratio 34.5 x 26.5 x 62.5 x 34.7 x 172 x 11.5 x 7.95 x 6.76 x
Yield 1.15% 0.71% 2.13% - - 0% 2.4% 5.88%
Capitalization / Revenue 3.68 x 2.65 x 1.98 x 1.08 x 1.4 x 0.74 x 0.68 x 0.65 x
EV / Revenue 4.95 x 3.86 x 3.34 x 2.59 x 2.82 x 2.02 x 1.81 x 1.67 x
EV / EBITDA 17.9 x 13.9 x 17.1 x 12.9 x 12.8 x 7.91 x 6.5 x 5.93 x
EV / FCF 161 x 25.7 x 52.1 x -56.7 x -213 x 27 x 20.1 x 15.3 x
FCF Yield 0.62% 3.9% 1.92% -1.76% -0.47% 3.7% 4.98% 6.52%
Price to Book 4.46 x 1.99 x 1.89 x 1.19 x 1.79 x 0.85 x 0.78 x 0.67 x
Nbr of stocks (in thousands) 684,135 684,540 682,484 678,911 678,665 679,092 - -
Reference price 2 31.43 23.88 16.88 10.77 15.46 8.742 8.742 8.742
Announcement Date 2/27/20 2/26/21 2/28/22 2/28/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,099 5,340 4,933 6,064 6,592 7,097 7,641 8,033
EBITDA 1 1,407 1,479 961.5 1,221 1,455 1,810 2,122 2,258
EBIT 1 1,131 996.1 595.1 805.7 1,023 1,290 1,585 1,648
Operating Margin 22.19% 18.65% 12.06% 13.29% 15.52% 18.17% 20.74% 20.51%
Earnings before Tax (EBT) 1 817.1 878.6 350.5 361.3 224 738.2 1,102 1,133
Net income 1 625.1 618.5 182.8 208.3 59.32 468.3 721.8 821.6
Net margin 12.26% 11.58% 3.71% 3.43% 0.9% 6.6% 9.45% 10.23%
EPS 2 0.9100 0.9000 0.2700 0.3100 0.0900 0.7570 1.099 1.294
Free Cash Flow 1 156.6 802.2 316.1 -277.4 -87.14 530.2 687.5 873.4
FCF margin 3.07% 15.02% 6.41% -4.57% -1.32% 7.47% 9% 10.87%
FCF Conversion (EBITDA) 11.13% 54.24% 32.87% - - 29.29% 32.4% 38.68%
FCF Conversion (Net income) 25.05% 129.7% 172.91% - - 113.23% 95.25% 106.3%
Dividend per Share 2 0.3600 0.1700 0.3600 - - 0.000100 0.2102 0.5140
Announcement Date 2/27/20 2/26/21 2/28/22 2/28/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 2,677 2,537 1,198 1,198 2,396 1,405 1,543 2,810 1,541 1,713 3,254 1,561 1,663 3,225 1,597 1,770 1,640 1,765 1,747 1,840
EBITDA 1 731.4 634.5 - - 327 248.2 - 618.3 308 294 602.7 298.8 360.7 659.5 373.6 426.3 366.4 459.4 456.1 -
EBIT 1 421.7 463.6 - - 131.5 - - 427.3 173.4 176.9 378.3 175.7 253.6 - 264.4 329.3 229.5 339.2 336 -
Operating Margin 15.75% 18.27% - - 5.49% - - 15.21% 11.25% 10.33% 11.63% 11.25% 15.25% - 16.55% 18.61% 13.99% 19.22% 19.23% -
Earnings before Tax (EBT) 1 - 378.2 - - -27.78 - - 227.9 66.69 46.88 133.4 -84.17 103.2 19.05 99.59 105.4 55.02 69.75 81.75 107.2
Net income 1 218.2 266.8 - - -84.01 - - 143.6 45 20.07 64.63 -108.3 52.04 -56.22 59.54 55.99 32.79 71.22 77.38 68.76
Net margin 8.15% 10.52% - - -3.51% - - 5.11% 2.92% 1.17% 1.99% -6.93% 3.13% -1.74% 3.73% 3.16% 2% 4.04% 4.43% 3.74%
EPS 2 - 0.3900 -0.0600 - -0.1200 - - 0.2100 - - 0.1000 - 0.0800 - - - 0.0665 0.1762 0.1725 0.0515
Dividend per Share - - - - - - - - - - - - - - - - - - - -
Announcement Date 7/30/20 7/29/21 2/28/22 2/28/22 2/28/22 7/28/22 7/28/22 7/28/22 11/8/22 2/28/23 2/28/23 5/9/23 7/27/23 7/27/23 11/2/23 2/28/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 6,465 6,436 6,695 9,158 9,337 9,098 8,581 8,181
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 4.595 x 4.352 x 6.963 x 7.501 x 6.419 x 5.027 x 4.044 x 3.623 x
Free Cash Flow 1 157 802 316 -277 -87.1 530 687 873
ROE (net income / shareholders' equity) 15.9% 12.5% 3.26% 3.57% 3.72% 9.02% 11.2% 11.5%
ROA (Net income/ Total Assets) 5.13% 4.01% 1.06% 1.02% 1.04% 2.14% 3.07% 3.06%
Assets 1 12,193 15,409 17,254 20,384 5,701 21,931 23,490 26,817
Book Value Per Share 2 7.050 12.00 8.950 9.040 8.640 10.30 11.20 13.00
Cash Flow per Share 2 0.8300 1.620 0.8800 -0.0200 0.3100 1.050 1.480 1.570
Capex 1 412 308 281 266 295 435 368 379
Capex / Sales 8.09% 5.77% 5.69% 4.39% 4.48% 6.12% 4.82% 4.72%
Announcement Date 2/27/20 2/26/21 2/28/22 2/28/23 2/28/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
8.742 EUR
Average target price
17.4 EUR
Spread / Average Target
+99.04%
Consensus
  1. Stock Market
  2. Equities
  3. GRF Stock
  4. Financials Grifols, S.A.